Recombinant NGF Manufacturing

• 

  The Journey of Recombinant NGF Manufacturing".

  Yaohai scientists have spent many years working hard to make Recombinant NGF. Undeterred, they began by studying the ways in which NGF operates within the body and its critical function in maintaining our nerve's overall well-being. In studying NGF, they went to learn how other labs create drugs so as to teach them the best practices.

• 

  Examining the Process of Recombinant NGF Manufacturing".

  Production of Recombinant NGF is not so simple. This process requires a number of intricate steps. At this stage, the scientists have to master creating special cells in a lab that produce NGF. These cells are critical because they will be the ones that produce the NGF people need. Next, the researchers need to coax these lab-created cells to generate NGF. But after the cells produce NGF, scientists must then wrestle it away from them. The NGF also will need to be purified, safe and ready for human use.

• 

  Exploring the Potential of Recombinant NGF Manufacturing".

  According to Yaohai, Recombinant NGF can assist a great numb of individual nerve issues as it is! The hope with this new medicine is that it will be less toxic and more potent than other kinds of NGF medicines on the market. Moreover, Recombinant NGF is likely to be easier and cheaper to manufacture. In doing so, this would mean more people would be able to take advantage of a very useful medicine that could improve their lives drastically.

Why choose Yaohai Recombinant NGF Manufacturing?

• Tvirta tiekimo grandinė ir gamybos galimybės

  Yaohai Bio-Pharma, a Recombinant NGF Manufacturing manufacturer of biological products, is a specialist in microbial fermentations. We have built a modern factory equipped with modern facilities and strong RD and manufacturing capabilities. Five drug substance production lines that are compliant with GMP standards for microbial purification and ferment, as well as two fill and finish lines for vials as well as cartridges, as well as needles that are pre-filled, are readily available. The available fermentation scales vary from 100L to 500L, 1000L, to 2000L. Filling volumes vary from 1ml to 25ml. Syringes or cartridges pre-filled are filled with the equivalent of 1-3ml. Our cGMP-compliant production facility ensures the availability of stable clinical samples and commercial products. The big molecules that are produced at our plant are readily available for international delivery.

• Kokybės sistema ir visuotinis reguliavimas

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality management and regulatory issues. We have developed a solid quality management system that conforms to the current GMP standards and regulations globally. Our regulatory team has an in-depth understanding of the world-wide regulatory frameworks. This allows us to accelerate biological launches. We ensure traceable production processes as well as high-quality products and in compliance with the guidelines of the US FDA and EU EMA. Recombinant NGF Manufacturing and China NMPA are also satisfied. Yaohai BioPharma successfully passed an on-site audit conducted by an accredited Qualified Person of the European Union (QP) to review our GMP system and production facility. We have also been through the first certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Pritaikymas, efektyvumas ir ekonomiškumas

  Yaohai Bio-Pharma has experience in the manufacture of biologics derived from microorganisms. We offer tailored RD solutions and manufacturing while minimizing the risk. We have worked with diverse methods, such as Recombinant NGF Manufacturing of vaccines (including peptides), growth factors, hormones, and Cytokines. We specialized in multiple microbial hosts, including yeast extracellular and intracellular (yield up to 15 g/L) bacteria periplasmic secretion, soluble intracellular, and inclusion bodies (yield up to 10 grams/L). We also have a BSL-2 fermentation platform to create bacterial vaccines. We specialize in improving processes, increasing product yields, as well as reducing production costs. We have an efficient technology team that guarantees timely and quality project delivery. This allows us to deliver your exclusive products quicker to market.

• Profesionali patirtis ir didelė patirtis

  Yaohai Bio-Pharma, a leader in CDMOs of microbial biologics, is headquartered in Jiangsu. We have been focused on microbially produced therapeutics and vaccines that are suited for human, veterinary and the management of Recombinant NGF Manufacturing. We have the most the most advanced RD as well as manufacturing technology platforms, which cover the entire process from Microbial strain engineering, cell banking as well as process and method development to commercial and clinical manufacturing, assuring the successful supply of the most cutting-edge solutions. We have accumulated a huge amount of experience in the bio processing of microbial cells. We have delivered over 200 projects across the globe and have assisted our clients with navigating the rules and regulations of the US FDA, EU EMA, Australia TGA, and China NMPA. Our expert knowledge and vast experience enable us to swiftly adapt to market needs and offer tailored CDMO services.

Susijusios produktų kategorijos

• Rekombinantinis kiaulių insulino biogamyba
• GMP rekombinantinių peptidų gamyba
• Rekombinantinis žmogaus kolageno gamybos procesas
• Rekombinantinis IGF-1 gamyba
• Rekombinantinio leptino gamyba
• Rekombinantinė Midkine gamyba
• Rekombinantinis Parkin baltymų gamyba
• Rekombinantinio naviko antigeno gamyba
• Rekombinantinio tipo 17 kolageno gamyba
• Rekombinantinis I tipo kolageno gamyba

Nerandate to, ko ieškote?
Norėdami gauti daugiau galimų produktų, susisiekite su mūsų konsultantais.